Evaluating the clinical application of the immune cells' ratios and inflammatory markers in the diagnosis of inflammatory bowel disease.

Mamoon M D Al-RshaidatShaima Al-SharifAssem Al RefaeiNour ShewaikaniBeisan A MohammadYaser M Rayyan

Published in: Pharmacy practice (2022)

Implications to our study include the clinical application of immune cell ratios, inflammatory markers, and their different combinations along with patients' history and physical examination findings for easier, faster, and more cost-effective diagnosis of IBDs.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes
ulcerative colitis